Evidence map›Paper›PMID 31150477›Full record

ArticlePloS one2019

Scaffold-based lung tumor culture on porous PLGA microparticle substrates.

Aneetta E Kuriakose, Wenjing Hu, Kytai T Nguyen, Jyothi U Menon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Advances in Engineering Human Tissue Models.Frontiers in bioengineering and biotechnology · 2020
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Three-Dimensional Spheroids for Cancer Research.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  9. Article
  10. Multiple Cell Cultures for MRI Analysis.International journal of molecular sciences · 2022
    Review
  11. The emergence of nanoporous materials in lung cancer therapy.Science and technology of advanced materials · 2022
    Review
  12. Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation.Materials science & engineering. C, Materials for biological applications · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Aneetta E KuriakoseBioengineering Department, University of Texas at Arlington, Arlington, Texas, United States of America.
Wenjing HuProgenitec Inc., Arlington, Texas, United States of America.
Kytai T NguyenBioengineering Department, University of Texas at Arlington, Arlington, Texas, United States of America.
Jyothi U MenonBioengineering Department, University of Texas at Arlington, Arlington, Texas, United States of America.ORCID 0000-0002-0762-3513
The University of Texas at Arlington · USProgenitec (United States) · USUniversity of Rhode Island · US

Funding

Training CoreP20GM103430 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI Christopher Lee Hemme · 2012 to 2026
$63.6M
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North TexasT32HL134613 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI NGUYEN, KYTAI TRUONG · 2017 to 2021
$1.1M
Multi-functional particles for stem cell isolation and expansionR41MH106303 · NIMH · PROGENITEC, INC. · PI HU, WENJING · 2014 to 2014
$200k
TISSUE ENGINEERED VASCULAR GRAFTSF32HL010380 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI NGUYEN, KYTAI TRUONG · 2000 to 2001
$66k
NHLBI NIH HHS F32 HL010380NHLBI NIH HHS T32 HL134613NIGMS NIH HHS P20 GM103430NIMH NIH HHS R41 MH106303
6 · The paper itself

Abstract

Scaffold-based cancer cell culture techniques have been gaining prominence especially in the last two decades. These techniques can potentially overcome some of the limitations of current three-dimensional cell culture methods, such as uneven cell distribution, inadequate nutrient diffusion, and uncontrollable size of cell aggregates. Porous scaffolds can provide a convenient support for cell attachment, proliferation and migration, and also allows diffusion of oxygen, nutrients and waste. In this paper, a comparative study was done on porous poly (lactic-co-glycolic acid) (PLGA) microparticles prepared using three porogens-gelatin, sodium bicarbonate (SBC) or novel poly N-isopropylacrylamide [PNIPAAm] particles, as substrates for lung cancer cell culture. These fibronectin-coated, stable particles (19-42 μm) supported A549 cell attachment at an optimal cell seeding density of 250,000 cells/ mg of particles. PLGA-SBC porous particles had comparatively larger, more interconnected pores, and favored greater cell proliferation up to 9 days than their counterparts. This indicates that pore diameters and interconnectivity have direct implications on scaffold-based cell culture compared to substrates with minimally interconnected pores (PLGA-gelatin) or pores of uniform sizes (PLGA-PMPs). Therefore, PLGA-SBC-based tumor models were chosen for preliminary drug screening studies. The greater drug resistance observed in the lung cancer cells grown on porous particles compared to conventional cell monolayers agrees with previous literature, and indicates that the PLGA-SBC porous microparticle substrates are promising for in vitro tumor or tissue development.

Indexed as

Cell Culture TechniquesTissue EngineeringCell AdhesionCell CountCell-Derived MicroparticlesCell ProliferationCell SurvivalDrug Evaluation, PreclinicalDrug Resistance, NeoplasmGelatinHumansLung NeoplasmsPolylactic Acid-Polyglycolic Acid CopolymerTissue ScaffoldsGelatinPolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID31150477
PMCPMC6544352
OpenAlexW2947165337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.